Skip to main content
EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?
Read on Becaris
First in class, best in class or a wild card: who will dominate the anti-obesity medication market?
Read on Becaris
Why is target trial emulation not being used in health technology assessment real-world data submissions?
Read on Becaris
Tackling health inequalities through the development of the wider public health workforce
Read on PubMed
RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment
Part 15
Part 16
A review of 25 years of National Institute of Health and Care Excellence decision making
Read on Becaris
Val (EU)xit: do we need an international ISPOR value flower?
Read on Becaris